Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy - Wikidata - wikimedia - TriplyDB

Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy

Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy

http://www.wikidata.org/entity/Q36007805

about

pH sensing and regulation in cancer Nuclear localization of the mitochondrial factor HIGD1A during metabolic stress Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors.Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors.Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment Combination therapy in combating cancer.Microenvironmental induced essentiality of autophagy Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions Contrasting effects of sunitinib within in vivo models of metastasis.Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer Combination of lactate calcium salt with 5-indanesulfonamide and α-cyano-4-hydroxycinnamic acid to enhance the antitumor effect on HCT116 cells via intracellular acidification Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy.Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment.The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine.Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies.Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors.The chemistry, physiology and pathology of pH in cancer.Current evidence of temozolomide and bevacizumab in treatment of gliomas.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update.Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.Dexamethasone downregulates expression of carbonic anhydrase IX via HIF-1α and NF-κB-dependent mechanisms.Hypoxia and cellular metabolism in tumour pathophysiology.CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo Methods: Using Three-Dimensional Culture (Spheroids) as an In Vitro Model of Tumour Hypoxia.

P2860

Q21129239-BFA0B114-326B-4733-B5B9-B1EA31C36F35 Q21133540-82988845-8357-4612-8E5C-0D779EF69360 Q26749333-5AEB17FB-E6B3-4851-BAB2-D0DEDD156C9D Q27025007-017F7F09-25BF-4DF1-80FB-648F420EDC76 Q28822228-DD7B7D4E-2C76-4565-8527-BB85971CED47 Q30985593-A3A1B605-4877-4BD3-AAEA-407677B8A9E4 Q33598505-F2653005-F91D-478C-A309-62CCD851FA91 Q33770680-7A732211-4F2F-4906-A550-4821D8BB62B4 Q33877411-5C0CDBD9-82FE-4A04-BBBE-5288F7755F41 Q33914234-58442493-35E5-4FEE-BED3-6123E8D5445F Q34589869-D3A35A21-1106-4801-B2EF-24C3FBE2721F Q34807753-867091D5-E0D8-431D-B824-11FB9D46B304 Q34851281-69023CBA-0C79-40C9-90E4-53DA9757D7AF Q35946329-1DEFC94E-32A1-4CB9-A873-4D1A9A3055D7 Q36394262-03FC140F-3343-426C-BCA8-E2499622FA38 Q36413042-4FDFB6D5-B653-42DB-9472-B10962C481A3 Q36569050-5F737E57-74CF-48C8-9E37-5A006114B5CD Q36640636-3C0E6BAA-55C9-4E1B-BA90-806C693909EC Q36729549-6A992B39-8ACC-4784-ACEC-BBDECC732B84 Q37050321-D7E9D2EA-9AF6-4C67-B7E0-3017512348D8 Q37185773-20F72A0B-0EB9-4576-A5F2-B746CBC86D97 Q37221629-8609A41C-4084-4052-9D6B-B581130442C2 Q37333948-C209AE45-23F1-424E-B66B-2872A1FE56E7 Q37562355-E85B192D-007D-473D-8DB8-5F45717ADEFB Q37699173-0AF542C4-761A-4C51-B33A-767EE5BBE652 Q37705814-2D2B1D88-258E-42EC-835B-810E18BF864F Q38123175-00554AB2-7A8D-4C40-B7BF-A1AB7C58CF45 Q38177264-0EEDCDA0-202B-4327-A783-CC4317742B0F Q38184982-17C4F037-DD1F-4D85-925D-7CED58AB5CE7 Q38230650-9030A034-161C-453E-B54F-83A1C493C20D Q38263008-9D467A4E-B6AD-41BA-982C-52600D875B73 Q38317180-51B04991-5047-45BB-995D-3EEFC90A9FBE Q38599484-E7E6C8D3-8752-4CAD-A090-BD2AFD53DD28 Q38734017-FECFF546-71EC-4619-84E6-25224F6E98FD Q38757226-233E2C8A-D8AA-42EC-90CD-23FBBF29964B Q38772023-40FB1AF5-81FC-452A-B24B-7E5F8D550FB2 Q38779789-F9023049-C42B-4F20-95C7-C6C32BBCD0DB Q38804116-EFBE9BE5-FA84-454D-8AC2-97DB3AF4184D Q38865279-7579A36F-DE41-4A70-A0EE-522E9D5317CD Q38871432-BE73FE5B-6154-447E-BC98-DB6736750B80

P2860

Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy

http://www.wikidata.org/entity/Q36007805

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Carbonic anhydrase IX promotes ...... ion enhances anti-VEGF therapy

@ast

Carbonic anhydrase IX promotes ...... ion enhances anti-VEGF therapy

@en

type

label

Carbonic anhydrase IX promotes ...... ion enhances anti-VEGF therapy

@ast

Carbonic anhydrase IX promotes ...... ion enhances anti-VEGF therapy

@en

prefLabel

Carbonic anhydrase IX promotes ...... ion enhances anti-VEGF therapy

@ast

Carbonic anhydrase IX promotes ...... ion enhances anti-VEGF therapy

@en

P1433

Q36007805-AAF77B4F-D369-4A0B-B6F8-82E3A2AB0815

P1476

Q36007805-F631DFC9-91DF-4BF0-A8CD-7A0FDB98D44C

P2093

Q36007805-27ECFAAC-F139-4D9E-8D08-B4B3F76252D1

Q36007805-5396D5E9-109D-4142-A63C-38DFB656AD36

Q36007805-842AB370-B30D-4A54-A48A-48710DE2342F

Q36007805-BA74550F-3FAA-46A8-9E1E-5D9AE0868D2E

Q36007805-BD2C77CB-9944-4239-9153-C63FAA7A129A

Q36007805-C8FC162D-7798-4888-939D-01E05D717DE5

Q36007805-DB727AD8-AD5F-497D-95EB-44F5B7440BD9

Q36007805-E46DE4F1-5810-454A-A759-D395AEFECBA9

Q36007805-EE0E08EB-97CD-47D0-B9BA-ED77EF9E64BF

Q36007805-F042F44A-EF5D-4AD3-B6BB-4F42CFD8EFB4

P2860

Q36007805-0412F502-0AA7-4BA6-8B67-913351E5EB37

Q36007805-06E42328-D6FD-4466-8687-10DE4B46B803

Q36007805-0B01A8B2-7384-4D39-A881-4E38BFEF9132

Q36007805-0CF28DF2-B9C3-4D1E-829D-981273228FEB

Q36007805-103EC6FF-52A1-4A1A-920A-99BA52BD3590

Q36007805-16D51C5A-0ADF-430D-82E1-869A8D6A7D36

Q36007805-1F4960AB-E9E2-42C0-AA45-830852426F1A

Q36007805-20CD96C5-4331-43AD-85BE-30EAB13D01CC

Q36007805-24300E70-A414-406D-9818-AF8DCEBE93B0

Q36007805-2F98C069-6272-491C-B885-AD258A1BDC1C

P304

Q36007805-0C92BCBF-AC44-473D-917F-7C17888E7A85

P31

Q36007805-26870428-B9D7-46C7-A3D7-CEFD13B16A74

P356

Q36007805-EFC947F4-AB9B-4A5D-A95A-1B2B25298694

P407

Q36007805-454BF6C4-E321-4854-BB6F-652F65DDE82C

P433

Q36007805-5983426B-A1BB-4443-AE35-C6E461401F53

P478

Q36007805-2C557418-E7DB-4AA2-8D75-7D77D2738D9E

P50

Q36007805-AFD03068-5B2C-4D99-A4AB-C0544904A314

Q36007805-F2817B66-5B30-424B-B0F5-E723C754DB8E

P577

Q36007805-4EB2F6AC-E786-46C1-A223-CC59DDBBEC16

P5875

Q36007805-9D53CB1E-E522-4007-85FA-4027E61D1BB4

P698

Q36007805-4450A50B-1BE0-49BE-B895-47C543CE5200

P932

Q36007805-7C1D20E6-1D59-4429-9B2B-BE98C3BA1128

P356

1078-0432.CCR-11-1877

P1433

Clinical Cancer Research

P1476

Carbonic anhydrase IX promotes ...... ion enhances anti-VEGF therapy

@en

P2093

Alan McIntyre

http://www.w3.org/2001/XMLSchema#string

Helen Turley

http://www.w3.org/2001/XMLSchema#string

Ioanna Ledaki

http://www.w3.org/2001/XMLSchema#string

Ji-Liang Li

http://www.w3.org/2001/XMLSchema#string

Kevin Gatter

http://www.w3.org/2001/XMLSchema#string

Pawel Swietach

http://www.w3.org/2001/XMLSchema#string

Richard D Vaughan-Jones

http://www.w3.org/2001/XMLSchema#string

Russell Leek

http://www.w3.org/2001/XMLSchema#string

Shalini Patiar

http://www.w3.org/2001/XMLSchema#string

Simon Wigfield

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast

Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

The Ki-67 protein: from the known and the unknown

Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer

Why do cancers have high aerobic glycolysis?

Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts

The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C

Hypoxia-inducible expression of tumor-associated carbonic anhydrases

P304

3100-3111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-11-1877

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Adrian L Harris

P577

2012-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224004626

http://www.w3.org/2001/XMLSchema#string

P698

22498007

http://www.w3.org/2001/XMLSchema#string

P932

3367109

http://www.w3.org/2001/XMLSchema#string